![]()
|
|
||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Papers In Press, published online ahead of print February 9, 2004
Biochemistry and Molecular Biology, Oregon Health Sciences University, Portland, OR 97201
Corresponding Author: LUH{at}OHSU.EDU
We recently reported that MDM2, a negative feedback regulator of the tumor suppressor p53, inhibits PCAF-mediated p53 acetylation. Our further study shows that MDM2 also regulates the stability of PCAF. MDM2 ubiquitinated PCAF in vitro and in cells. PCAF ubiquitination occurred at the N-terminus and in the nucleus, as the NLS sequence-deletion mutant of MDM2, which localized in the cytoplasm and degraded p53, was unable to degrade nuclear PCAF, and restriction of PCAF in the nucleus by leptomycin B did not affect MDM2-mediated PCAF degradation. Consistently, overexpression of MDM2 in p53 null cells caused the reduction of the protein, but not mRNA, level of PCAF. Conversely, PCAF levels were higher in MDM2-deficient MEF cells than that in MDM2-containing MEF cells. Furthermore, MDM2 reduced the half-life of PCAF by 50 %. These results demonstrate that MDM2 regulates the stability of PCAF by ubiquitinating and degrading this protein.
J. Biol. Chem, 10.1074/jbc.M309916200
Submitted on September 8, 2003
Revised on February 7, 2004
Accepted on February 9, 2004
MDM2 mediates PCAF ubiquitination and degradation
![]()
CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
Technorati What's this?
This article has been cited by other articles:
![]() |
J. R. Gallegos, J. Litersky, H. Lee, Y. Sun, K. Nakayama, K. Nakayama, and H. Lu SCF TrCP1 Activates and Ubiquitylates TAp63{gamma} J. Biol. Chem., January 4, 2008; 283(1): 66 - 75. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Cherasse, A.-C. Maurin, C. Chaveroux, C. Jousse, V. Carraro, L. Parry, C. Deval, C. Chambon, P. Fafournoux, and A. Bruhat The p300/CBP-associated factor (PCAF) is a cofactor of ATF4 for amino acid-regulated transcription of CHOP Nucleic Acids Res., September 27, 2007; 35(17): 5954 - 5965. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Lacroix, R.-A. Toillon, and G. Leclercq p53 and breast cancer, an update. Endocr. Relat. Cancer, June 1, 2006; 13(2): 293 - 325. [Abstract] [Full Text] [PDF] |
||||
![]() |
Z. P. Desgranges, J. Ahn, M. B. Lazebnik, T. Ashworth, C. Lee, R. C. Pestell, N. Rosenberg, C. Prives, and A. L. Roy Inhibition of TFII-I-Dependent Cell Cycle Regulation by p53 Mol. Cell. Biol., December 15, 2005; 25(24): 10940 - 10952. [Abstract] [Full Text] [PDF] |
||||
![]() |
Z. ZHANG, H. WANG, M. LI, E. RAYBURN, S. AGRAWAL, and R. ZHANG Novel MDM2 p53-Independent Functions Identified through RNA Silencing Technologies Ann. N.Y. Acad. Sci., November 1, 2005; 1058(1): 205 - 214. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Brady, N. Vlatkovic, and M. T. Boyd Regulation of p53 and MDM2 Activity by MTBP Mol. Cell. Biol., January 15, 2005; 25(2): 545 - 553. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Gaughan, I. R. Logan, D. E. Neal, and C. N. Robson Regulation of androgen receptor and histone deacetylase 1 by Mdm2-mediated ubiquitylation Nucleic Acids Res., January 7, 2005; 33(1): 13 - 26. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH |
| All ASBMB Journals | Molecular and Cellular Proteomics |
| Journal of Lipid Research | ASBMB Today |